9 hrs ago | NC Mental Hope News
Should kids get these drugs? -Tacoma (WA) News Tribune
“Bipolar disorder is a very debilitating disease”
Should kids get these drugs? - Tacoma News Tribune M. ALEXANDER OTTO alex.otto@thenewstribune.com May 11, 2008 Concerned about how anti-psychotic drugs are being used in children, state officials are working on ... via NC Mental Hope News
Wednesday May 14 | International Herald Tribune
AstraZeneca's Seroquel given FDA approval for treating patients with bipolar disorder
LONDON : AstraZeneca PLC said Wednesday that U.S. regulators have approved its anti-psychotic drug Seroquel as a maintenance treatment for patients with bipolar I disorder. via International Herald Tribune
Wednesday May 14 | PharmaExec.com
Hopkins Researchers Discover New Link to Schizophrenia; Mouse Model Mimics Clinical Features
Neuroscientists at Johns Hopkins have discovered that mice lacking an enzyme that contributes to Alzheimer's disease exhibit a number of schizophrenia-like behaviors. via PharmaExec.com
Monday May 12 | Dermatology Times
Drug safety: Isotretinoin makers to comply with new FDA monitoring plan
“While the details of the REMS are still being worked out, we do not believe that the approved REMS will be substantially different from the existing risk management plans unless new safety information suggests that the existing plan is not working”
Isotretinoin manufacturers waiting to see if iPLEDGE will meet FDA's new safety guidelines National report - Manufacturers of isotretinoin are awaiting more information to determine whether iPLEDGE - the ... via Dermatology Times
Saturday May 10 | WebMD Health News
Ginseng May Help Treat Schizophrenia
“There's a signal here; the fact that Panax ginseng works on the same brain receptors [as antipsychotic drugs] makes it something to look at”
A form of Asian ginseng shows promise for relieving schizophrenia symptoms that are difficult to treat. via WebMD Health News
Friday May 9 | Med Ad News
Overview of Asenapine Data from Olympia Trial Program Presented at...
“Therefore, new therapies that are both effective and well-tolerated would be welcome additions to the treatment options currently available for improving patient care.”
Schering-Plough Corporation today announced that an overview of asenapine clinical trials from the Olympia program was presented at the 161st Annual Meeting of the American Psychiatric Association in ... via Med Ad News
Thursday May 8 | Scientific Blogging
BACE1 Enzyme Linked To Schizophrenia
“These mice were totally disinterested, normal mice just don't behave like this”
Submitted by News Account on 8 May 2008 - 12:00am. Psychobiology Neuroscientists at Johns Hopkins have discovered that mice lacking an enzyme that contributes to Alzheimer disease exhibit a number of ... via Scientific Blogging
Wednesday May 7 | Earth Times
'CNS Generic Drugs: Prospects and Opportunities to 2012' Now Available
Research and Markets has announced the addition of CNS Generic Drugs: Prospects and Opportunities to 2012 to their offering. via Earth Times
Tuesday May 6 | EurekAlert!
Data presented at the APA Annual Meeting
“The data from the clinical trials studying the efficacy and safety of iloperidone suggest that iloperidone could be a useful long-term treatment option for people with schizophrenia”
Data presented today on Vanda Pharmaceuticals Inc.'s investigational drug candidate, iloperidone, included its 4-week, short-term Phase III trial, as well as a pooled analysis of three long-term, 52-week ... via EurekAlert!
Monday May 5 | Daily Mail
Anti-psychotic drug use soars in UK children
“This highlights the need for long-term safety investigations and ongoing clinical monitoring, particularly if the prescribing rate of these medicines continues to rise.”
Comments The drug Risperdal is used to treat schizophrenia and symptoms of bipolar disorder The number of children being treated with anti-psychotic drugs has risen sharply, according to a new study. via Daily Mail







